TRIB2 and prostate carcinoma: A comprehensive gene expression array analysis revealed that the TRIB2 pseudokinase is grossly overexpressed in enzalutamide-resistant (EN1 and EN2) prostate cancer cells, compared to parental enzalutamide sensitive (LN1 and LN2) cells (Fig. 1, A–D).